Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China flag China · Delayed Price · Currency is CNY
25.30
-0.10 (-0.39%)
May 6, 2026, 3:04 PM CST

SHE:300357 Ratios and Metrics

Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
May '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
13,24714,84410,63915,18428,84930,001
Market Cap Growth
14.32%39.52%-29.93%-47.37%-3.84%-25.29%
Enterprise Value
12,03013,6179,54714,16027,83929,137
Last Close Price
25.3028.2620.0328.3253.5055.38
PE Ratio
31.1138.9733.4848.9582.7288.76
Forward PE
27.2033.3526.8038.4162.0969.52
PS Ratio
12.1913.9711.5017.9032.2037.15
PB Ratio
4.695.474.336.5914.2316.70
P/TBV Ratio
5.076.014.867.5015.6818.27
P/FCF Ratio
49.7654.7979.9298.21180.74126.95
P/OCF Ratio
33.7635.0840.5439.7480.0883.20
EV/Sales Ratio
11.0712.8210.3216.7031.0736.07
EV/EBITDA Ratio
24.9229.9226.4541.8569.1879.58
EV/EBIT Ratio
28.2733.5930.0846.1372.8684.20
EV/FCF Ratio
45.1950.2671.7291.59174.41123.29
Debt / Equity Ratio
0.010.010.010.030.010.00
Debt / EBITDA Ratio
0.040.040.070.180.040.02
Debt / FCF Ratio
0.070.070.190.400.100.03
Net Debt / Equity Ratio
-0.46-0.52-0.52-0.53-0.55-0.56
Net Debt / EBITDA Ratio
-2.74-3.11-3.57-3.62-2.78-2.77
Net Debt / FCF Ratio
-4.90-5.22-9.68-7.93-7.01-4.29
Asset Turnover
0.390.380.350.360.430.46
Inventory Turnover
0.910.900.770.750.830.68
Quick Ratio
24.1111.598.588.4313.7211.76
Current Ratio
26.1412.189.058.8714.3812.42
Return on Equity (ROE)
15.42%14.24%12.78%13.65%17.56%19.63%
Return on Assets (ROA)
9.48%9.04%7.53%8.06%11.56%12.23%
Return on Invested Capital (ROIC)
25.95%27.95%23.55%26.42%38.04%40.22%
Return on Capital Employed (ROCE)
14.80%14.70%12.60%12.90%18.20%19.00%
Earnings Yield
3.21%2.57%2.99%2.04%1.21%1.13%
FCF Yield
2.01%1.82%1.25%1.02%0.55%0.79%
Dividend Yield
0.98%0.89%1.10%0.65%0.37%0.36%
Payout Ratio
27.07%30.27%30.66%34.05%30.17%24.79%
Buyback Yield / Dilution
0.01%0.01%0.00%0.00%0.00%-0.00%
Total Shareholder Return
0.99%0.89%1.10%0.65%0.38%0.36%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.